Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions.
Schavgoulidze A, Perrot A, Cazaubiel T, Leleu X, Montes L, Jacquet C, Belhadj K, Brechignac S, Frenzel L, Chalopin T, Rey P, Schiano de Collela JM, Dib M, Caillot D, Macro M, Fontan J, Buisson L, Pavageau L, Roussel M, Manier S, Mohty M, Martinet L, Avet-Loiseau H, Corre J. Schavgoulidze A, et al. Among authors: schiano de collela jm. Blood Cancer J. 2023 Oct 26;13(1):160. doi: 10.1038/s41408-023-00933-4. Blood Cancer J. 2023. PMID: 37880285 Free PMC article. No abstract available.
Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma.
El Cheikh J, Kfoury E, Calmels B, Lemarie C, Stoppa AM, Bouabdallah R, Coso D, Schiano De Collela JM, Ladaique P, Gastaut JA, Mohty M, Chabannon C, Blaise D. El Cheikh J, et al. Among authors: schiano de collela jm. Hematol Oncol Stem Cell Ther. 2011;4(1):30-6. doi: 10.5144/1658-3876.2011.30. Hematol Oncol Stem Cell Ther. 2011. PMID: 21460604 Free article.
Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution.
Broussais-Guillaumot F, Coso D, Belmecheri N, Ivanov V, Schiano de Collela JM, Aurran-Schleinitz T, Stoppa AM, Chetaille B, Xerri L, Esterni B, Blaise D, Bouabdallah R. Broussais-Guillaumot F, et al. Among authors: schiano de collela jm. Leuk Lymphoma. 2013 Nov;54(11):2392-8. doi: 10.3109/10428194.2013.776680. Epub 2013 Mar 27. Leuk Lymphoma. 2013. PMID: 23410100
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Damaj G, Gressin R, Bouabdallah K, Cartron G, Choufi B, Gyan E, Banos A, Jaccard A, Park S, Tournilhac O, Schiano-de Collela JM, Voillat L, Joly B, Le Gouill S, Saad A, Cony-Makhoul P, Vilque JP, Sanhes L, Schmidt-Tanguy A, Bubenheim M, Houot R, Diouf M, Marolleau JP, Béné MC, Martin A, Lamy T. Damaj G, et al. Among authors: schiano de collela jm. J Clin Oncol. 2013 Jan 1;31(1):104-10. doi: 10.1200/JCO.2012.43.7285. Epub 2012 Oct 29. J Clin Oncol. 2013. PMID: 23109692 Clinical Trial.
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity.
Garciaz S, Coso D, Schiano de Collela JM, Broussais F, Stoppa AM, Aurran T, Chabannon C, Helvig A, Xerri L, Blaise D, Bouabdallah R. Garciaz S, et al. Among authors: schiano de collela jm. Bone Marrow Transplant. 2016 Feb;51(2):319-21. doi: 10.1038/bmt.2015.257. Epub 2015 Nov 2. Bone Marrow Transplant. 2016. PMID: 26524266 No abstract available.
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Coso D, Sebban C, Boulat O, Biron P, Rey J, Aurran T, Chabannon C, Xerri L, Chetaille B, Esterni B, Ivanov V, Stoppa AM, Schiano de Collela JM, Gastaut JA, Maraninchi D, Bouabdallah R. Coso D, et al. Among authors: schiano de collela jm. Bone Marrow Transplant. 2006 Aug;38(3):217-22. doi: 10.1038/sj.bmt.1705414. Epub 2006 Jun 12. Bone Marrow Transplant. 2006. PMID: 16770316 Clinical Trial.